Device type · NEU
Marker, Radiographic, Implantable
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NEU
General & Plastic Surgery
Device class
Class II
FDA decisions since 2015
54
510(k), De Novo and PMA
Adverse event reports
292
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Marker, Radiographic, Implantable
- Product code
- NEU
- Device class
- Class II
- Review panel
- General & Plastic Surgery
- Regulation
- 21 CFR 878.4300
- Specialty
- General & Plastic Surgery
- FDA record
- Classification database entry for NEU
Latest FDA decisions
The 8 newest of 54 since 2015.
Devicor Medical Products, Inc.
K253761 · Decided Jan 23, 2026 · 59 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
- MOLLI 2 System510(k)
K253888 · Decided Dec 31, 2025 · 27 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
K252892 · Decided Dec 19, 2025 · 99 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
K251989 · Decided Dec 12, 2025 · 168 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
Carbon Medical Technologies, Inc.
K251748 · Decided Jul 23, 2025 · 47 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
Bard Peripheral Vascular, Inc.
K243642 · Decided Mar 24, 2025 · 118 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
K233639 · Decided Dec 20, 2024 · 403 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
- Trilogy Tissue Marker510(k)
K240429 · Decided Nov 7, 2024 · 268 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
Reports received
292
Received Nov 1, 2025 to Nov 19, 2026. Includes 5 of another or unstated type.
Malfunction reports
81
28% of reports
Injury reports
206
71% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 3 | 0 | 0 |
| Jan 24 | 0 | 4 | 0 | 0 |
| Feb 24 | 4 | 9 | 0 | 0 |
| Mar 24 | 6 | 10 | 0 | 0 |
| Apr 24 | 4 | 20 | 0 | 0 |
| May 24 | 3 | 23 | 0 | 0 |
| Jun 24 | 3 | 23 | 0 | 0 |
| Jul 24 | 4 | 10 | 0 | 0 |
| Aug 24 | 1 | 38 | 0 | 0 |
| Sep 24 | 2 | 23 | 0 | 0 |
| Oct 24 | 1 | 22 | 0 | 0 |
| Nov 24 | 5 | 15 | 0 | 0 |
| Dec 24 | 2 | 15 | 0 | 0 |
| Jan 25 | 3 | 25 | 0 | 0 |
| Feb 25 | 4 | 22 | 0 | 0 |
| Mar 25 | 13 | 163 | 0 | 0 |
| Apr 25 | 0 | 42 | 0 | 0 |
| May 25 | 7 | 25 | 0 | 0 |
| Jun 25 | 3 | 26 | 0 | 0 |
| Jul 25 | 2 | 14 | 0 | 0 |
| Aug 25 | 1 | 16 | 0 | 0 |
| Sep 25 | 4 | 13 | 0 | 0 |
| Oct 25 | 6 | 12 | 0 | 0 |
| Nov 25 | 1 | 3 | 0 | 0 |
| Dec 25 | 2 | 10 | 0 | 0 |
| Jan 26 | 11 | 3 | 0 | 0 |
| Feb 26 | 3 | 6 | 0 | 0 |
| Mar 26 | 6 | 13 | 0 | 0 |
| Apr 26 | 5 | 9 | 0 | 0 |
| May 26 | 7 | 115 | 0 | 0 |
| Jun 26 | 4 | 9 | 0 | 0 |
| Jul 26 | 6 | 7 | 0 | 0 |
| Aug 26 | 7 | 9 | 0 | 2 |
| Sep 26 | 7 | 10 | 0 | 2 |
| Oct 26 | 22 | 12 | 0 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Hologic195
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem167
- Migration33
- Use of Device Problem11
- Incorrect, Inadequate or Imprecise Result or Readings9
- Premature Activation6
- Break5
- Component Missing5
- Communication or Transmission Problem4
- Device Appears to Trigger Rejection4
- Material Fragmentation4
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Breast Discomfort/Pain106
- No Clinical Signs, Symptoms or Conditions80
- Breast Mass61
- Seroma29
- Swelling/ Edema29
- Insufficient Information27
- Erythema20
- Bacterial Infection15
- Hypersensitivity/Allergic reaction15
- Foreign Body In Patient14
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0187-2027 · Started Aug 27, 2026 · Posted by FDA Oct 15, 2026
Reason given: The implantable clip may experience difficulties deploying, which could prevent the reflector from functioning as intended during use.
Cause as FDA categorized it: Process control
- HydroMARK Breast Biopsy Site Marker, Model Number: 4010-02-15-T3Open, Classified
Z-2239-2026 · Started Apr 24, 2026 · Posted by FDA May 27, 2026
Reason given: Incorrect inner package labeling. Boxes labeled 4010-02-15-T3 markers may contain individual packages labeled as T4 Markers.
Cause as FDA categorized it: Labeling mix-ups
Z-1427-2026 · Started Jan 21, 2026 · Posted by FDA Feb 17, 2026
Reason given: Due to a need to update the product labeling (Instructions for Use IFU) as a result of the magnetized surgical tools dislodging markers using during target tissue removal procedures.
Cause as FDA categorized it: Under Investigation by firm
Z-0316-2026 · Started Oct 1, 2025 · Posted by FDA Oct 24, 2025
Reason given: Potential for contamination with cotton fibers.
Cause as FDA categorized it: Process control
Z-0317-2026 · Started Oct 1, 2025 · Posted by FDA Oct 24, 2025
Reason given: Potential for contamination with cotton fibers.
Cause as FDA categorized it: Process control
Z-0806-2025 · Started Nov 18, 2024 · Posted by FDA Jan 6, 2025
Reason given: There is a potential safety risk caused by physical disassociation of the back section from the bed frame of Skytron model series 3600, 6500, 6600 and 6700 operating room beds when used with the EnVisio Navigation System.
Cause as FDA categorized it: Device Design
- BioZorb Marker. Radiographic soft tissue marker.Open, Classified
Z-0328-2025 · Started Oct 10, 2024 · Posted by FDA Nov 26, 2024
Reason given: Firm received reports of adverse events/complications that include serious injuries, such as pain, infection, rash, device migration, device erosion, seroma, and discomfort.
Cause as FDA categorized it: Device Design
Z-1733-2024 · Started Mar 13, 2024 · Posted by FDA May 3, 2024
Reason given: Safety Information: Complaints describe complications/adverse events that include pain, infection, rash, device migration, device erosion, seroma, discomfort, or other complications from feeling the device in the breast, and the need for additional medical treatment to remove the device
Cause as FDA categorized it: Unknown/Undetermined by firm
Showing the 8 newest of 15 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.